BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21636708)

  • 1. High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression.
    Zhang J; Huang K; Shi Z; Zou J; Wang Y; Jia Z; Zhang A; Han L; Yue X; Liu N; Jiang T; You Y; Pu P; Kang C
    Neuro Oncol; 2011 Jun; 13(6):600-9. PubMed ID: 21636708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCTP promotes glioma cell proliferation in vitro and in vivo via enhanced β-catenin/TCF-4 transcription.
    Gu X; Yao L; Ma G; Cui L; Li Y; Liang W; Zhao B; Li K
    Neuro Oncol; 2014 Jan; 16(2):217-27. PubMed ID: 24311645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma.
    Chen L; Huang K; Han L; Shi Z; Zhang K; Pu P; Jiang C; Kang C
    Int J Oncol; 2011 Oct; 39(4):883-90. PubMed ID: 21720709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
    Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
    Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling.
    Chen L; Han L; Zhang K; Shi Z; Zhang J; Zhang A; Wang Y; Song Y; Li Y; Jiang T; Pu P; Jiang C; Kang C
    Neuro Oncol; 2012 Aug; 14(8):1026-36. PubMed ID: 22649212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.
    Wang K; Wang X; Zou J; Zhang A; Wan Y; Pu P; Song Z; Qian C; Chen Y; Yang S; Wang Y
    Neuro Oncol; 2013 May; 15(5):578-88. PubMed ID: 23416699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
    Yu X; Wang M; Wu J; Han Q; Zhang X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-glycosylation gene DPAGT1 is a target of the Wnt/beta-catenin signaling pathway.
    Sengupta PK; Bouchie MP; Kukuruzinska MA
    J Biol Chem; 2010 Oct; 285(41):31164-73. PubMed ID: 20693288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.
    Sánchez-Tilló E; de Barrios O; Siles L; Cuatrecasas M; Castells A; Postigo A
    Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19204-9. PubMed ID: 22080605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
    Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
    Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription.
    Antony L; van der Schoor F; Dalrymple SL; Isaacs JT
    Prostate; 2014 Aug; 74(11):1118-31. PubMed ID: 24913829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes.
    Narasipura SD; Henderson LJ; Fu SW; Chen L; Kashanchi F; Al-Harthi L
    J Virol; 2012 Feb; 86(4):1911-21. PubMed ID: 22156527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation.
    Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G
    J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets.
    Kavak E; Najafov A; Ozturk N; Seker T; Cavusoglu K; Aslan T; Duru AD; Saygili T; Hoxhaj G; Hiz MC; Unal DO; Birgül-Iyison N; Ozturk M; Koman A
    Cell Signal; 2010 Oct; 22(10):1523-35. PubMed ID: 20538055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KLF4 and SOX9 transcription factors antagonize β-catenin and inhibit TCF-activity in cancer cells.
    Sellak H; Wu S; Lincoln TM
    Biochim Biophys Acta; 2012 Oct; 1823(10):1666-75. PubMed ID: 22766303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
    Xie D; Yin D; Tong X; O'Kelly J; Mori A; Miller C; Black K; Gui D; Said JW; Koeffler HP
    Cancer Res; 2004 Mar; 64(6):1987-96. PubMed ID: 15026334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling.
    Chen L; Zhang A; Li Y; Zhang K; Han L; Du W; Yan W; Li R; Wang Y; Wang K; Pu P; Jiang T; Jiang C; Kang C
    Cancer Lett; 2013 Feb; 329(2):174-80. PubMed ID: 23142218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.